Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BHCHX vs. QAAGZX: which is better?

Bottom line

BHCHX vs QAAGZX: the short answer

BHCHX (Baron Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 50% by weight.

But QAAGZX is far broader, holding 277 positions to 43 for BHCHX, so beyond the top names it adds exposure BHCHX doesn't have.

BHCHX is cheaper at 0.85% vs 0.86% — a difference of $1.00 a year per $10,000 invested.

Over five years, QAAGZX returned +4.1% a year vs +2.8% for BHCHX.

Updated Nov 19, 2026

BHCHX vs QAAGZX side by side

BHCHXQAAGZX
TypeMutual fundETF
Fund familyBaron SelectT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.85%0.86%
Annual cost per $10k$85$86
10-yr cost on $10k (prospectus)$1,049$1,061
Max front load—None
12b-1 fee0%0%
1-yr return+10.3%+18.1%
5-yr return (annualized)+2.8%+4.1%
10-yr return (annualized)—+9.0%
Best quarter—+23.4%
Worst quarter—−15.8%
Net assets (fund)$114.1M$751.7M
Number of holdings43277
Portfolio turnover74%65%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

13 of BHCHX's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingBHCHXQAAGZX
Eli Lilly & Co13.66%14.06%
Johnson & Johnson5.56%6.64%
Thermo Fisher Scientific Inc3.91%2.53%
UnitedHealth Group Inc3.28%5.88%
Vertex Pharmaceuticals Inc2.61%2.26%
Merck & Co Inc2.48%4.00%
Guardant Health Inc2.17%1.22%
Kymera Therapeutics Inc2.01%0.89%
Gilead Sciences Inc1.99%2.79%
Natera Inc1.93%1.44%
Intuitive Surgical Inc1.74%1.89%
Protagonist Therapeutics Inc1.72%0.85%
Elevance Health Inc1.69%1.54%

Source: SEC Form N-PORT

BHCHX top 10

  1. Eli Lilly & Co — 13.66%
  2. Mettler-Toledo International Inc — 5.60%
  3. Johnson & Johnson — 5.56%
  4. Argenx SE — 4.23%
  5. Thermo Fisher Scientific Inc — 3.91%
  6. Roivant Sciences Ltd — 3.88%
  7. Teva Pharmaceutical Industries Ltd — 3.86%
  8. Welltower Inc — 3.38%
  9. UnitedHealth Group Inc — 3.28%
  10. RadNet Inc — 3.24%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between BHCHX and QAAGZX?
BHCHX (Baron Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 50% by weight. But QAAGZX is far broader, holding 277 positions to 43 for BHCHX, so beyond the top names it adds exposure BHCHX doesn't have.
Which is cheaper, BHCHX or QAAGZX?
BHCHX has the lower expense ratio (0.85%).
Should I own both BHCHX and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.